LFA-1 antagonists - Mitsubishi Tanabe Pharma
Alternative Names: LFA-451; LFA-819Latest Information Update: 26 May 2010
Price :
$50 *
At a glance
- Originator Tanabe Seiyaku
- Class
- Mechanism of Action Lymphocyte function-associated antigen-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Transplant rejection
Most Recent Events
- 26 May 2010 Discontinued - Preclinical for Autoimmune disorders in Austria (unspecified route)
- 26 May 2010 Discontinued - Preclinical for Autoimmune disorders in Japan (unspecified route)
- 26 May 2010 Discontinued - Preclinical for Autoimmune disorders in Switzerland (unspecified route)